Sotyktu Tablet, Film Coated
Product Images NDC 0003-0895

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sotyktu (NDC 0003-0895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure (Chem Structure)

FDA Label Image

Deucravacitinib-principal-display-panel-label.jpg (Deucravacitinib Principal Display Panel Label)

Deucravacitinib-principal-display-panel-label.jpg (Deucravacitinib Principal Display Panel Label)
The text is a list of items including "WCOmT 30 Tables" and "SOTYKTUS" and mentions "deucravacitinib" tablets for oral use by Bristol Myers. No additional information or context is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.